Online inquiry

IVTScrip™ mRNA-Anti-MAG, GSK-249320(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (CAT#: GTTS-WQ7902MR)

This product GTTS-WQ7902MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets MAG gene. The antibody can be applied in Stroke research.

Specifications
Product type	mRNA
Modified bases	N1-Methylpseudo-UTP
5' Cap	Cap 1
Species	Humanized
RefSeq	NM_001199216.2
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	4099
UniProt ID	P20916

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-MAG, GSK-249320(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WQ7902MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ15601MR	IVTScrip™ mRNA-Anti-SLC29A2, VAL-1221(Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	VAL-1221
GTTS-WQ1459MR	IVTScrip™ mRNA-Anti-CD22, ACD22-VCMMAE(Cap 0, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	ACD22-VCMMAE
GTTS-WQ9960MR	IVTScrip™ mRNA-Anti-hly, KBSA301(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	KBSA301
GTTS-WQ5579MR	IVTScrip™ mRNA-Anti-IL13, CDP7766(Cap 0, Pseudo-UTP, 120 nt-poly(A))	mRNA	CDP7766
GTTS-WQ12898MR	IVTScrip™ mRNA-Anti-TNF, OPRX-106(Cap 1, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	OPRX-106
GTTS-WQ8615MR	IVTScrip™ mRNA-Anti-CD33, HuM195(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	HuM195
GTTS-WQ1104MR	IVTScrip™ mRNA-Anti-MAPT, ABBV-8E12(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	ABBV-8E12
GTTS-WQ1745MR	IVTScrip™ mRNA-Anti-IL2RA, ADCT-301(Cap 1, Pseudo-UTP, 30 nt-poly(A))	mRNA	ADCT-301

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST